HIMS Stock Analysis: Buy, Sell, or Hold?
HIMS - Hims & Hers Health, Inc.
$34.38
0.00 (0.00%)
▲
5d:
-10.19%
30d:
+23.76%
90d:
+76.94%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 03, 2026
19d
Smart Money Accumulation
None View Scanner →
Strength: 7.4/10
Get Alerted When HIMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
18 traders called HIMS this week
80% bullish • 4 bearish
80% bullish • 4 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HIMS trades at premium valuation expecting 6.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: HIMS trades at premium valuation expecting 6.1% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$23.47
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$14.57
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HIMS is currently trading at $34.38, which is considered slightly high relative to its 30-day fair value range of $29.06 to $36.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 51.3) compared to its historical average (42.9). At these levels, the market is pricing in 6.1% annual earnings growth.
Technical Outlook: Technically, HIMS is in a strong uptrend. Immediate support is located at $31.59, while resistance sits at $39.05.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $28.42. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HIMS is in a strong uptrend. Immediate support is located at $31.59, while resistance sits at $39.05.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $28.42. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$29.06 -
$36.00
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
59.0%
Protect Your Profits
Holding HIMS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 17.3% above Wall St target ($28.42)
- BULLISH: Expecting earnings turnaround to 6.1% growth with 3.8% revenue growth
- CAUTION: 5-day price weakness (-10.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$29.06 -
$36.00
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$31.60
Resistance Level
$39.05
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
51.31
Wall Street Target
$28.42
(-17.3%)
Revenue Growth (YoY)
3.8%
Earnings Growth (YoY)
-17.4%
Profit Margin
-0.6%
Valuation Premium vs History
+6.1% premium
PE vs Historical
51.3 vs 42.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.1%
(market-implied from PE analysis)
1-Year Target
$36.48
(+6%)
2-Year Target
$38.70
(+13%)
3-Year Target
$41.06
(+19%)
3-Yr Target (if PE normalizes)
(PE: 51→43)
PE COMPRESSION
$34.33
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 13, 2026 7:27 PM ET
Data refreshes hourly during market hours. Next update: 8:27 PM
Data refreshes hourly during market hours. Next update: 8:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HIMS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Soleil Boughton
SELL
9463 shares
2026-04-20
Oluyemi Okupe
SELL
19645 shares
2026-04-20
Oluyemi Okupe
SELL
18005 shares
2026-04-17
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 51 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
Advanced HIMS Option Strategies
Professional options setups generated by AI based on today's HIMS price and gamma walls.
